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hyperbaric oxygenation in severe sepsis
induced by cecal ligation and puncture in
rats
Nina Falcon Bærnthsen1,2* , Marco Bo Hansen1,2, Anna Mygind Wahl1,2, Ulf Simonsen3 and Ole Hyldegaard1,2
Abstract
Background: Septic shock remains a leading cause of death worldwide. Hyperbaric oxygen treatment (HBO2) has
been shown to alter the inflammatory response during sepsis and to reduce mortality. A therapeutic window of
HBO2 treatment has been demonstrated experimentally, but optimal timing remains uncertain. We investigated the
effects of 24 h delayed normobaric oxygen (NBO2) and HBO2 treatment on the endogenous production of the
inflammatory markers interleukin (IL)-6, tumor necrosis factor (TNF)-α and IL-10, and on mortality in rats with cecal
ligation and puncture (CLP) induced sepsis.
Method: Fifty-five male Sprague-Dawley rats underwent CLP and were randomized to the following groups: 1)
HBO2 2.5 bar absolute pressure (pabs); 2) NBO2 1.0 bar pabs; 3) Control (no-treatment), and they were individually
monitored for 72 h with intermittent blood sampling.
Results: IL-6, TNF-α, and IL-10 were increased 24 h after the procedure, and IL-6 was significantly higher in non-survivors
than in survivors. The level of IL-10 was significantly higher at hour 48 in the HBO2 group compared to control (p = 0.01),
but this was not the case at other time points. No other significant differences in cytokine levels were found for any
group comparisons. Delayed NBO2 and HBO2 treatment failed to change the mortality in the animals.
Conclusion: High levels of IL-6 in non-surviving animals with sepsis suggest that IL-6 is a potential biomarker. We found a
significantly higher concentration of IL-10 in the HBO2 group at hour 48 vs. control animals. However, 24 h–delayed
treatment with HBO2 did not change the levels of pro-inflammatory cytokines and survival, suggesting that earlier
intervention may be required to obtain an anti-inflammatory effect.
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Background
Sepsis is a common and critical illness that accounts for
750.000 deaths annually in the United States despite in-
creased focus and improved treatment [1–4]. The exces-
sive release of cytokines causes a hyper inflammatory
state and the imbalance of the pro-inflammatory and
anti-inflammatory responses is thought to contribute to
the high mortality rates in sepsis [5]. In particular, high
concentrations of tumor necrosis factor (TNF)-α and
interleukin (IL)-6 have been associated with multi organ
failure and death at Day 28 [6]. Expression of IL-10 has
been suggested to protect against mortality [7, 8]. How-
ever, others have shown that mortality is highest when
both anti-inflammatory and pro-inflammatory cytokine
levels are elevated [5, 9].
Hyperbaric oxygen treatment (HBO2) is currently the pri-
mary treatment for patients with carbon monoxide poison-
ing, decompression sickness, and an adjunctive treatment
for problematic wound healing including necrotizing soft
tissue infections [10, 11]. Sepsis is associated with an
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increased formation of reactive oxygen species (ROS) in-
volved in tissue damage. Even though hyperoxia might in-
crease ROS production, hyperbaric hyperoxia triggered
repair mechanisms such as increasing the antioxidative cap-
acity and improving microcirculation seems of importance,
and therefore HBO2 has been suggested as a treatment for
sepsis [12, 13]. Data from animal studies of sepsis suggest
that HBO2 reduces mortality by altering the inflammatory
response with an up-regulated anti-inflammatory response
and down-regulated pro-inflammatory response [14, 15].
Previous reports have established that early treatment with
hyperbaric oxygen has a beneficial effect on anti-
inflammatory parameters and on mortality, but at present it
is unclear whether delayed intervention with HBO2 has ef-
fect on the manifest stage of septic shock [7, 16, 17]. More-
over, cytokine concentrations are often only measured at
one time point in each animal e.g. prior to euthanization,
thus eliminating the chance of investigating the dynamic
changes in the individual animal over time [7, 18, 19].
In the present study we aimed to investigate
whether sampling and monitoring cytokine levels at
several time points during 72 h relate to mortality
and whether delayed treatment with normo- or
hyperbaric oxygenation (i.e. NBO2 or HBO2) has a
modulating effect on the cytokine response in mani-
fest sepsis. CLP-induced sepsis in rats is considered
the gold standard for the induction of inflammatory
responses because the method causes a septic re-
sponse similar to that of humans [20, 21]. Therefore,
we combined CLP-induced sepsis with intermittent
blood sampling monitoring the endogenous produc-
tion of IL-6, TNF-α and IL-10 in rats over 72 h. We
hypothesized that HBO2 treatment would result in a
decreased pro-inflammatory response and an in-
creased anti-inflammatory response thereby lowering
mortality.
Methods
Ethics
The study was approved by the Danish Animal Ex-
periment Inspectorate (authorization number 2012–
12–2934-00504). The animals were assessed every 8th
hour by the investigator (NFB) for clinical signs of
sepsis. If an animal was too severely affected, it had
to be euthanized according to Danish law. The sever-
ity of sepsis was evaluated using objective criteria ac-
cording to clinical observations including the rats
alertness [22]. Signs of severe suffering due to sepsis
should be handled with euthanization of the rat, al-
though this never happened. The study complied with
the national guidelines for the care and use of ani-
mals in experimental research. The manuscript was
prepared according to the ARRIVE (Animal Research:
Reporting of In Vivo Experiments) guidelines.
Animals
Male Sprague-Dawley rats aged 8–10 weeks with an
average weight of 296 g were used in all experiments.
The rats were maintained, single caged, in a controlled
environment (room temperature 22–23 °C and 50% hu-
midity). They were housed for 120 h before surgery to
allow acclimatization to the environment and they were
maintained under a 12 h light/12 h dark regime. Food
and water were available ad libitum.
Surgical procedures
All surgical procedures were conducted under aseptic con-
ditions. Body temperature was controlled with a heating
pad to maintain body temperature close to 37 °C degrees.
Body temperature was measured with a probe inserted in
the rectum. The rats were anesthetized with a single shot of
intramuscular administered Zoletil 0.25 mL/100 g to keep
the animals asleep and pain free during the entire surgical
procedure. The animals were anesthetized a total of two
times during the research period: Once prior to CLP and
once before termination after 72 h to allow cardiac punc-
ture. All incisions were closed using 4–0 PDS*II suture.
Post-surgery fluid resuscitation was administered once with
saline 20 mL/kg intraperitonally and analgesia was provided
with buprenorphine 0.05 mg/kg every 8 h.
Femoral venous catheter
While anesthetized, using aseptic technique, a femoral
venous catheter was placed for blood sampling, tunneled
under the skin to the back of the neck and placed in a har-
ness (Instech Solomon, order no. CIH95AB) to be easy ac-
cessible for sampling. The catheter was placed through a
5 mm incision in the right inguinal area. The femoral vein
was found using blunt dissection and the tunnel was made
by guiding forceps subcutaneously to the level of the in-
guinal area. A small incision was made 1/3 through the
vein at an angle of 45 degrees. The catheter was placed in
the vein and forwarded approximately 2–3 cm into the
vein. Afterwards it was secured with 5–0 ethilon*II suture
in the muscle layer of the leg. After insertion and blood
sampling the catheter was flushed with 1 mL of saline also
functioning as fluid resuscitation. A total of 3 mL was
drawn during the 72 h observation period and before the
rat was anesthetized for termination corresponding to ap-
proximately 15% of the total blood volume [22]. This is
considered in accordance to guidelines and should not
cause significant circulatory- or oxygenation problems
since blood is sampled over several days [23].
Cecal ligation and puncture
The rat was shaved in the surgical area before the pro-
cedure and the skin sterilized with 0.5% chlorhexidine
gluconate 83% ethanol. A 2 cm midline incision was
made in the abdominal wall using scissors. The cecum
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was located and 30% of the cecum length was tightly li-
gated with a 4–0 silk suture, the ligation being below the
ileocecal valve to ensure the continuity of the gastro-
intestinal tract and otherwise according the procedures
described by Rittirsch et al. and Hubbard et al. [21, 24].
The cecum was then punctured once from side to side
(double puncture) with a 16G needle. The cecum was
gently squeezed until a small amount (droplet) of feces
was visible through the punctures. The cecum was relo-
cated into the abdominal cavity without spreading feces
to the abdominal wall wound and the abdominal wall
and skin was closed by sutures using 4–0 PDS*II suture.
After the rat recovered from anesthesia, they had access
to food and water ad libitum.
Experimental design and protocol
We randomized 55 rats into the following three groups,
all rats undergoing CLP:
1) 19 rats exposed to hyperbaric oxygen (HBO2) (100%
oxygen; 2.5 bar absolute pressure (pabs)).
2) 18 rats exposed to normobaric oxygen (NBO2)
(100% oxygen; 1.0 bar pabs).
3) 18 rats served as controls (no treatment).
Rats were randomized (via Microsoft Excel) on a
weekly basis amongst all valid combinations, the same
group not following each other thereby assuring random
group allocation. All normo- or hyperbaric oxygen treat-
ments lasted for 90 min, the first treatment being ad-
ministered with a delay of 24 h from the time of CLP.
Subsequently, NBO2 or HBO2 were administered at 32,
48, 56 and 72 h after CLP, i.e. the last NBO2 or HBO2
treatment were followed by immediate termination by
exsanguination (Fig. 1).
One mL of blood was aseptically collected from the fem-
oral vein catheter immediately prior to CLP and subse-
quently at hour 24, 48 and 72 after CLP. After each sample
was collected, 1 mL of saline was carefully administered
over one minute to compensate for the blood collected. If
the catheter was obstructed, this was recorded, blood was
drawn via sublingual blood collection using a 23G syringe
dripping the blood directly into the sample tube, here giv-
ing 1 mL of saline intramuscular At 72 h, the animals were
anesthetized with Zoletil 0.25 mL/100 g and blood for cul-
turing and cytokine measurements were drawn by cardiac
puncture under sterile conditions. Immediately afterwards,
all animals were terminated by exsanguination.
Hyperbaric oxygen treatment
We administered 100% O2 for 90 min at 1.0 or 2.5 bar
absolute pressure. The treatments were given in an Oxy-
com 250 Arc cylindrical acrylic hyperbaric chamber de-
signed for animal research. The pressure inside the
chamber was increased at the rate of 0.3 bar/min and
decompressed at the rate of 0.3 bar/min. In the normo-
baric treatment the chamber was only ventilated with
oxygen without increasing the pressure inside the cham-
ber. The concentration of O2 was continuously mea-
sured with a DAMECA OM781 oxygen monitor. The
hyperbaric chamber was ventilated with pure oxygen
during the entire treatment to prevent CO2 accumula-
tion and to maintain the exact pressure.
Laboratory methods
Blood cultures
One-3 mL of blood was inoculated in Bactec™ Peds Plus
culture vials for aerobic microorganisms. Subsequent cul-
turing and identification of the bacterial isolates was per-
formed according to standard microbiological methods by
the Department of Clinical Microbiology, Sect. 9301,
Copenhagen University Hospital, Rigshospitalet.
Luminex multiplex assay
Quantitative determination of IL-6, TNF-α and IL-10 con-
centrations in plasma was done using BioRad Bioplex Sys-
tem, Luminex MAP Technology (Copenhagen, Denmark)
according to the manufacturer’s specifications. Analysis
was performed at Aarhus University Hospital and at the
Department of Biomedicine, Aarhus University. The
Fig. 1 Experimental protocol showing interventions on a timeline. Intervention being either hyperbaric oxygen treatment, normobaric oxygen treatment
or no intervention (control). CLP, cecal ligation and puncture. Blood = 1 ml of full blood withdrawn for analysis and substituted by 1 ml 0.9% NaCl
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plasma was obtained from whole blood centrifuged at
2400G/3500 rpm for 10 min. The plasma supernatant was
pipetted and placed in 1 mL cryo tubes stored at minus 80
degrees Celsius for later analysis.
Outcome measures
Our primary analysis focused on describing changes of the
pro- and anti-inflammatory response during the develop-
ment of CLP induced sepsis expressed as differences in
IL-6, TNF-α and IL-10 concentrations. Furthermore, we
assessed the impact of HBO2 and NBO2 treatments on
plasma cytokine concentrations at 24 h, 48 h and 72 h
during the phases of sepsis progression. In the secondary
analysis, we analyzed differences in mortality over 72 h be-
tween the HBO2 and NBO2 group.
Data analysis and statistics
Tests for normality and homogeneity of variance were con-
ducted using the Shapiro-Wilks test and the Kolmogorov-
Smirnov test. Due to non-parametric distribution, continu-
ous data are reported as medians (interquartile range). For
categorical data, absolute numbers (proportions) are re-
ported and group comparisons performed using χ2-test or
Fisher’s exact test. Continuous data are reported with me-
dians (interquartile range, IQR) and compared at specific
time points using the Mann-Whitney U test. The mortality
was calculated using the log-rank test and illustrated with
Kaplan-Meier curves (Fig. 2). P-values <0.05 were consid-
ered statistically significant. Statistical analyses were per-
formed using Statistical Package for the Social Sciences
22.0 software (SPSS Inc., Chicago, IL, USA) and GraphPad
Prism 6.0 software (GraphPad Inc., La Jolla, CA, USA).
Cytokine measurements with values lower than detection
concentrations were set to 0.5 times the lowest value mea-
sured for statistical analysis.
Results
In total, 58 rats underwent operation with CLP and in-
sertion of femoral vein catheter. Three died as a result of
operative complications, leaving 55 rats for inclusion.
Baseline characteristics of all experimental groups are
shown in Table 1. Except for weight, there were no dif-
ferences among groups in baseline characteristics. In
spite of group randomization procedures, the weight of
the rats was significantly different among the groups
with rats in the HBO2 (median weight 309 g) weighing
significantly more than the NBO2 group (median weight
281 g) (p = 0.0001).
Mortality
In total, there was a 42% mortality (8 died out of 19)
during the observation period in rats treated with HBO2,
whereas we saw 50% mortality (9 died out of 18) in rats
treated with NBO2 group and 61% mortality in the con-
trol group (11 died out of 18). Treatment with 2.5 bar
pabs HBO2 did not alter the survival significantly com-
pared with NBO2 treatment at any hours (24 h, p = 0.13,
48 h, p = 0.63 and 72 h, p = 0.63). Additionally, we found
no statistically significant difference in cumulative sur-
vival between the HBO2 group and the NBO2 group (p
= 0.59, log-rank test), between the HBO2 group and the
control group (p = 0.24, log-rank test) or between the
NBO2 group and the control group (p = 0.59, log-rank
test) (Fig. 2).
Fig. 2 Kaplan-Meier curves showing the percentage survival in HBO2, NBO2 and control group during 72 h. HBO2, hyperbaric oxygen treatment;
NBO2, normobaric oxygen treatment. HBO2 group compared to NBO2 group p = 0.59. HBO2 group compared to the control group p = 0.24. NBO2
group compared to the control group p = 0.59. Groups are compared using log-rank test
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Blood cultures
The predominant bacteria isolated included Escherichia coli
(E. coli) and Enterococcus Faecalis (E. faecalis) (Table 1).
Other bacteria isolated included Enterococcus Gallinarum,
Enterobacter cloacae (E. cloacae), Proteus Mirabilis,
Staphylococcus Sciuri, Ochrobactrum Anthropi and Strep-
toccocus Suis. The results showed no statistically significant
difference in the number of surviving rats with a positive
blood culture at hour 72 in the NBO2 group (44%, 4/9)
compared with the HBO2 group (82%, 9/11) (p = 0.16) and
no statistically significant difference between the groups ac-
cording to the number of animals presenting with polymi-
crobial blood cultures (p = 0.77) (Table 1).
Cytokines
Tables 2, 3 and 4 show the differences in the median
cytokine concentration at hour 0, 24, 48 and 72. The dif-
ference between HBO2 and both NBO2 and control
groups was calculated for all three cytokines. We found
a statistically significant difference between HBO2
(489.4 pg/mL; IQR 332.7–650.1) and control /228.6 pg/
mL; IQR 40.4–313.2) according to the anti-inflammatory
IL-10 at hour 48, however this was not the case for the
other time points (hour 0, p = 0.82; hour 24, p = 0.94;
hour 48, p = 0.01; hour 72, p = 0.60). We found no statis-
tically significant difference between HBO2 and control
at any time point according to the pro-inflammatory IL-
6 (hour 0, p = 0.06; hour 24, p = 0.85; hour 48, p = 0.97;
hour 72, p = 0.86) and TNF-α (hour 0, p = 0.48; hour 24,
p = 0.85; hour 48, p = 0.36; hour 72, p = 0.72). Neither
did we find any statistically significant difference be-
tween HBO2 and NBO2 at any time point according to
Table 1 Baseline characteristics and outcomes
Control (n = 18) NBO2 (n = 18) HBO2 (n = 19) P-value
Weight, gram (SD) 296 (24) 281 (14) 309 (25) < 0.0001
Temp. at beginning of OP, C° (SD) 36.2 (0.7) 36.4 (0.9) 36.2 (0.6) 0.54
Temp. at end of operation, C° (SD) 36.7 (0.6) 36.4 (0.4) 35.4 (0.4) 0.97
Operation time, minutes (IQR) 50 (45–58) 47 (34–56) 50 (40–64) 0.37
Caecum ligated, millimeters (SD) 62.9 (6.7) 60.8 (6.5) 60.3 (6.8) 0.81
Microorganisma
Positive blood culture 4 (57) 4 (44) 9 (82) 0.16
Polymicrobial 2 (29) 3 (33) 3 (27) 0.77
Escherichia coli 4 (57) 3 (33) 6 (55) 0.41
Enterococcus faecalis 1 (14) 3 (33) 2 (18) 0.62
Other 2 (29) 3 (33) 4 (36) 0.89
Cytokinesb, pg/mL
TNF-α 57.2 (0.4–114.9) 11.9 (0.4–118.7) 25.7 (0.4–102.9) 0.99
IL-6 33.4 (2.8–70.0) 2.8 (2.8–153.2) 2.8 (2.8–30.5) 0.87
IL-10 79.4 (0.1–155.9) 0.1 (0.1–278.8) 64.7 (0.1–148.5) 0.66
Blood drawn sublinguallyc
No of subjects 7 (17) 10(22) 9(17)
Mortality
24-h 6 (33) 8 (44) 4 (21) 0.13
48-h 10 (56) 9 (50) 8 (42) 0.63
72-h 11 (61) 9 (50) 8 (42) 0.63
CLP cecal ligation and puncture, NBO2 normobaric oxygen, HBO2 hyperbaric oxygen, Temp. temperature, IL interleukin, TNF tumor necrosis factor, SD standard
deviation, IQR interquartile range, OP operation
Differences between the NBO and HBO groups were tested using Chi-square test/Fisher’s exact test, student’s unpaired t-test or Mann-Whitney U-test
aBlood sampling on rats alive at time = 72 h (control n = 7; NBO n = 9; HBO n = 11). Values are reported as number of subjects (%)
bBaseline cytokine concentrations taken after CLP procedure at time = 0 h. Values are reported as mean (IQR)
cNo of samples drawn sublingually. In total 26 of 117 cases, the femoral vein catheter was obstructed. Values are reported as number of subjects (%)
Table 2 Differences in median TNF-α concentration
Hours HBO2 NBO2 Control
0 25.7 (0.4–102.9) 11.9 (0.4–188.7) 57.2 (0.4–114.9)
24 59.4 (0.4–138.5) 33.5 (0.4–136.3) 64.0 (0.4–157.8)
48 9.5 (0.4–74.0) 0.4 (0.4–93.2) 47.0 (1.2–137.6)
72 55.8 (0.4–122.4) 62.1 (0.4–125.5) 5.1 (0.4–131.8)
TNF-α tumor necrosis factor alfa, CLP cecal ligation and puncture, NBO2
normobaric oxygen treatment, HBO2 hyperbaric oxygen treatment
Values denote medians with IQR. Comparisons were performed using the
Mann-Whitney U-test. No significant differences (p< 0.05) were found comparing
HBO2 with NBO2 and HBO2 with control
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the pro-inflammatory IL-6 (hour 0, p = 0.87; hour 24, p
= 0.98; hour 48, p = 0.91; hour 72, p = 0.94) and TNF-α
(hour 0, p = 0.99; hour 24, p = 0.88; hour 48, p = 0.97;
hour 72, p = 0.94). This was also the case for the anti-
inflammatory IL-10 (hour 0, p = 0.66; hour 24, p = 0.31;
hour 48, p = 0.13; hour 72, p = 0.37).
We assessed the concentration of cytokines on hour
24 on all animals alive longer than 24 h after CLP. We
grouped them in survivors (alive until 72 h after CLP)
and non-survivors (died between 24 and 72 h after
CLP). We found non-survivors to have a significant
higher IL-6 concentration at 24 h compared to survivors
(non-survivors IL-6302.3 pg/mL (102.8–581.6) vs. survi-
vors IL-6 = 107.9 pg/mL (20.5–252.2), (p = 0.04)). There
was no statistically difference in the concentration of
TNF-α and IL-10 between survivors and non-survivors
(non-survivors TNF-α = 59.37 pg/mL (0.37–179.8) vs.
survivors TNF-α 37.52 pg/mL (0.37–122.6), p = 0.31;
non-survivors IL-10 = 1050 pg/mL (274.1–5318) vs. sur-
vivors IL-10 = 450.2 pg/mL (342.2–627.4), p = 0.13).
Discussion
In this study, we evaluated delayed intervention of
hyperbaric oxygen as a treatment for sepsis. We found
no difference in the concentrations of IL-6, TNF-α and
IL-10 between the groups treated with hyperbaric or
normobaric oxygen during the first 72 h of sepsis. How-
ever, we found a significantly higher concentration of IL-
10 at hour 48 in the HBO2 group compared with the
control group, but not at any other time points. More-
over, we found a significantly higher concentration of
IL-6 at hour 24 in non-survivors compared to survivors.
Lastly, we found no difference in survival rates between
all the treatment groups.
In previous reports, the experimental animals were ei-
ther terminated or anesthetized at varied time points in
order to collect samples and to obtain knowledge of cyto-
kine concentrations at different time points [8, 19, 25, 26].
This weakens longitudinal conclusions and results in a lar-
ger amount of animal sacrifice. In the present study, each
rat was monitored with intermittent blood sampling
which allows evaluation of the changes in cytokine con-
centrations on a daily basis and to follow each rat indi-
vidually. In addition, we were able to reduce the number
of rats by 75% and still obtain the same number of sam-
ples, which gives this study an enormous ethical advan-
tage. Moreover, it is a strength that we have combined the
gold standard of sepsis induction models with intermittent
blood sampling in the individual rat making the model ap-
plicable to clinical practice with respect to the study of dif-
ferent interventions, alone or in combination [20].
The present study uses only clinical signs and blood cul-
tures to ensure that the animals are septic, since earlier
studies have shown that CLP imitates sepsis according to
vascular derangement, alterations in the metabolic state
and with clinical signs showing disease [15, 20, 27]. In this
study we found that 63% of the blood cultures were posi-
tive (Table 1) with E. coli, E. Faecalis and E. cloacae as the
most frequent bacteria isolated, corresponding to periton-
itis from fecal matter. A post mortem laparotomy was per-
formed in all animals, disclosing a necrotic cecum tightly
adherent to close-lying anatomical structures, including
signs of peritonitis with excessive cloudy intraperitoneal
fluid combined with a foul smell. The information from
the clinical symptoms and signs in combination with the
positive blood cultures and the laparotomy findings sug-
gest that all rats were septic.
Sepsis is a critical illness currently treated with fluids
and antibiotics. Turnbull et al. has demonstrated that anti-
biotics can improve the outcome in murine sepsis lower-
ing overall mortality, but if a concentration of 14,000 pg/
mL of IL-6 is reached, the animals are destined to die des-
pite antibiotic treatment [28]. High plasma concentrations
of IL-6 in humans are also associated with the develop-
ment of septic shock and is a predictor of mortality [5,
29–31]. The current experiment confirms that IL-6 was a
predictor of death with a significantly higher concentra-
tion of IL-6 in non-surviving animals at 24 h indicating a
state of septic shock (Table 5). As shown by Singleton KD
and Wischmeyer PE, CLP distance and size of needle
puncture determines mortality. Performing a 30% CLP
with a 16G double-puncture as in the current experiment
should give a 90% mortality after 72 to 96 h [19].
Table 3 Differences in median IL-6 concentration
Hours HBO2 NBO2 Control
0 2.8 (2.8–30.5) 2.8 (2.8–153.2) 33.4 (2.8–70.0)
24 161.5 (14.6–296.5) 197.9 (2.8–278.6) 144.3 (53.4–322.9)
48 2.8 (2.8–77.9) 2.8 (2.8–101.3) 2.8 (2.8–95.5)
72 5.5 (2.8–134.9) 2.8 (2.8–224.7) 2.8 (2.8–182.6)
IL interleukin, CLP cecal ligation and puncture, NBO2 normobaric oxygen
treatment, HBO2 hyperbaric oxygen treatment
Values denote medians with IQR. Comparisons were performed using the Mann-
Whitney U-test. No significant differences (p< 0.05) were found comparing HBO2
with NBO2 and HBO2 with control
Table 4 Differences in median IL-10 concentration
Hours HBO2 NBO2 Control
0 64.7 (0.1–148.5) 0.1 (0.1–278.8) 79.4 (0.1–155.9)
24 591.0 (336.2–969.1) 405.8 (296.6–579.9) 517.2 (289.6–1138)
48 489.4 (332.7–650.1)* 337.8 (203.6–453.4) 228.6 (40.4–313.2)*
72 250.9 (99.4–330.5) 72.5 (0.1–538.5) 169.5 (585.8–0.1)
IL interleukin, CLP cecal ligation and puncture, NBO2 normobaric oxygen
treatment, HBO2 hyperbaric oxygen treatment
Values denote medians with IQR. Comparisons were performed using the
Mann-Whitney U-test
*: p = 0.01 comparing parameter in HBO2 vs. control. No other significant
differences (p < 0.05) were found comparing HBO2 with NBO2 and HBO2
with control
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Accordingly, the severity of the model presented here, in
combination with the high expression of IL-6 at 24 h mea-
sured before oxygen intervention, indicates this study ap-
plies to a severe state of sepsis.
It has been suggested that HBO2 might exert its effect
through production of the anti-inflammatory IL-10,
which acts by lowering the pro-inflammatory IL-6 and
thereby reducing mortality [5, 7, 18, 29, 30]. IL-10 has
furthermore been demonstrated to play a critical step in
the progression to a lethal state of sepsis and that en-
dogenous production of IL-10 delays the onset of mor-
tality in CLP induced sepsis [18]. In the present study,
we found a significantly higher concentration of IL-10 at
hour 48 in the HBO2 group compared with control. This
finding is in accordance to previous studies showing that
HBO2 treatment might boost the production of IL-10
[7]. In this study, we found no statistical difference in
the mortality between the HBO2 group and the control
group, hence the statistically higher concentration of IL-
10 in the HBO2 group at 48 h did not influence survival.
Interestingly, we found no significant difference between
HBO2 and NBO2 in the concentrations of IL-6, TNF-α
and IL-10 at any hours. Overall, the concentration of all
three measured cytokines decreased after the first 24 h.
This is probably due to the most severely ill animals
dying within the first 24 h of the study. The cytokine
value on hour 24 and forth may therefore represent less
ill animals, explaining the lower values of both pro- and
anti-inflammatory cytokines as measured. As later de-
scribed, the cytokine concentrations on Day 0 fluctuated
greatly and may have contributed to the lack of statisti-
cally significant results in the measured cytokines.
Buras et al. examined the effect of HBO2 treatment ac-
cording to survival in septic mice and found that two daily
treatments at 2.5 atm with a 12-h interval and a total of
eight treatments were required to reduce mortality [7].
They also found that NBO2 had no effect in terms of sur-
vival. In the present study, HBO2 was delayed by 24 h after
CLP-induction of sepsis, whereas Buras et al. administered
two HBO2 sessions within the first 24 h [7]. Undoubtedly,
the 24 h delay of the HBO2 treatment were fatal to overall
survival in this CLP model, although the treatment pres-
sure was chosen with reference in Buras et al.’s studies [7].
The delay of treatment was chosen to study the rats in a
circulatory hypodynamic state of sepsis, which follows the
initial hyperdynamic state and subsequently progresses
into a state of severe sepsis [32]. Experimentally, early
intervention with hyperbaric oxygen has been shown to
ameliorate sepsis. In most studies, however, the treatment
is given shortly after induction of sepsis before the signs of
manifest sepsis appear [7, 14]. In clinical practice, how-
ever, we cannot treat sepsis before the symptoms and
signs appear. Moreover, logistic challenges and patient
transfer between hospitals and other procedures can delay
hyperbaric oxygen treatment. Therefore, the chosen delay
of the hyperbaric treatment in this report reflects clinical
practice. However, the delay also constitute a limitation
since many animals die before the first intervention.
There are some other limitations of the present study.
Firstly, no sample size calculation was performed prior to
the experiment, which increases the risk of a type II error
due to a potential insufficient number of animals included
in each group. However, others studies have investigated
sepsis and outcomes in animals using similar sample size,
which is why we chose the number of animals in the
current study [7, 15, 18]. Secondly, the cytokine concentra-
tions on Day 0 varied greatly (see Tables 2, 3 and 4 for con-
centrations). It is well known in animal models to see a
stress response from anesthesia, which can vary between
the animals, however in the current study it varied greater
than we expected. It is important to outline, that the base-
line sample was taken prior to CLP hence no infection was
present yet. The fluctuating concentrations on Day 0 may
have contributed to the lack of statistically significant results
in cytokines concentrations between groups. Thirdly, al-
though rats were randomized by groups a difference oc-
curred in rat weight at the time of inclusion (Table 1).
Minor changes in weight (< 10%) induced by high fat diet
has earlier been shown to be associated with increased oxi-
dative stress and inflammation causing increased rat mortal-
ity in CLP models of sepsis [33, 34]. However, our rats were
all fed standard chow so a worsening effect of the weight is
not to be expected. The weight differences could be related
to differences in age at the time of randomization, but all
rats were provided similar acclimatization of 1½ week and
previous reports have failed to find any correlation between
age, weight and final outcome in similar CLP models [35].
Finally, as the Kaplan-Mayer curves show (Fig. 2) most of
the mortality occurred during the first 24 h and therefore
before the various treatment modalities were commenced.
This means that NBO2 and HBO2 therapies were studied in
a small number of rats, hence the size of the surviving
group may have been too small to demonstrate a possible
beneficial effect. Measurements of other biomarkers e.g. nu-
clear protein high mobility group box protein 1 (HMGB1)
Table 5 Difference between survivors and non-survivors in
median cytokine levels at hour 24
Non-survivors Survivors P-value
TNF-α 59,37 (0.37–179.8) 37.52 (0.37–122.6) 0.31
IL-10 1050 (274.1–5318) 450.2 (342.2–627.4) 0.13
IL-6 302.3 (102.8–581.6) 107.9 (20.5–252.2) 0.04*
Survivors defined as rats alive until 72 h after CLP, non-survivors defined as
rats dead between 24 and 72 h after CLP
IL interleukin, TNF-α Tumor necrosis factor alfa, CLP cecal ligation and puncture
Values denote medians with IQR. Comparisons were performed using the
Mann-Whitney U-test
*p= 0.04 comparing parameter in survivors vs. non-survivors. No other significant
differences (p < 0.05) were found
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has emerged in sepsis, and we cannot exclude other bio-
markers to link to survival in our model [36].
Conclusion
This study documents the endogenous production of IL-6,
TNF-α and IL-10 in rats with cecal ligation and puncture
(CLP) induced sepsis on conscious animals with intermit-
tent blood sampling in the individual rat during a 72-h
period. We found a significant higher level of IL-6 in non-
surviving animals, suggesting IL-6 to be a potential bio-
marker predicting death in sepsis. Moreover, we found a
statistically higher concentration of the IL-10 in the HBO2
group at hour 48 versus control animals, but the elevation
of the anti-inflammatory cytokine did not have a statisti-
cally significant effect on mortality. This might be due to
the 24 h delay of the HBO2 treatment. We found no add-
itional statistically significant differences in the cytokine
response between HBO2, NBO2 and control. Additionally,
no statistically significant differences were seen in mortal-
ity for any group comparisons. Delayed and infrequent
intervention in the late phase of septic shock may com-
promise the previously reported ameliorating effects of
HBO2 treatment. The model presented in this study pro-
vides a template for further preclinical studies in the field
of hyperbaric oxygen treatment for sepsis and future stud-
ies should consider earlier intervention with respect to
hyperbaric oxygen effects.
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